Rebolj M - Search Results

1

The challenges of organising cervical screening programmes in the 15 old member states of the European Union.

Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, Andrae B. Arbyn M, et al. Among authors: rebolj m. Eur J Cancer. 2009 Oct;45(15):2671-8. doi: 10.1016/j.ejca.2009.07.016. Epub 2009 Aug 18. Eur J Cancer. 2009. PMID: 19695867

2

Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands.

Bos AB, Rebolj M, Habbema JD, van Ballegooijen M. Bos AB, et al. Among authors: rebolj m. Int J Cancer. 2006 Nov 15;119(10):2372-5. doi: 10.1002/ijc.22114. Int J Cancer. 2006. PMID: 16858676 Free article.

3

Cervical cancer screening policies and coverage in Europe.

Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, Nicula F, Vass L, Valerianova Z, Voti L, Sauvaget C, Ronco G. Anttila A, et al. Among authors: rebolj m. Eur J Cancer. 2009 Oct;45(15):2649-58. doi: 10.1016/j.ejca.2009.07.020. Epub 2009 Aug 19. Eur J Cancer. 2009. PMID: 19699081

4

Process performance of cervical screening programmes in Europe.

Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, Kurtinaitis J, Lancucki L, Lynge E, Morais A, O'Reilly M, Sparen P, Suteu O, Rebolj M, Veerus P, Zakelj MP, Anttila A. Ronco G, et al. Among authors: rebolj m. Eur J Cancer. 2009 Oct;45(15):2659-70. doi: 10.1016/j.ejca.2009.07.022. Epub 2009 Aug 25. Eur J Cancer. 2009. PMID: 19713100

5

False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definition.

Rebolj M, Pribac I, Lynge E. Rebolj M, et al. Eur J Cancer. 2011 Jan;47(2):255-61. doi: 10.1016/j.ejca.2010.08.010. Eur J Cancer. 2011. PMID: 20833033

6

Impact of technology on cytology outcome in cervical cancer screening of young and older women.

Rask J, Lynge E, Franzmann M, Hansen B, Hjortebjerg A, Rygaard C, Schledermann D, Wåhlin A, Rebolj M. Rask J, et al. Among authors: rebolj m. Int J Cancer. 2014 May 1;134(9):2168-79. doi: 10.1002/ijc.28532. Epub 2013 Oct 24. Int J Cancer. 2014. PMID: 24122730 Free article.

7

Mortality of non-participants in cervical screening: Register-based cohort study.

Dugué PA, Lynge E, Rebolj M. Dugué PA, et al. Among authors: rebolj m. Int J Cancer. 2014 Jun 1;134(11):2674-82. doi: 10.1002/ijc.28586. Epub 2013 Nov 29. Int J Cancer. 2014. PMID: 24288241 Free article.

8

Cervical cancer screening at crossroads.

Lynge E, Rygaard C, Baillet MV, Dugué PA, Sander BB, Bonde J, Rebolj M. Lynge E, et al. Among authors: rebolj m. APMIS. 2014 Aug;122(8):667-73. doi: 10.1111/apm.12279. APMIS. 2014. PMID: 25046198 Review.

9

Cervical cancer screening in the Faroe Islands.

Hammer T, Lynge E, Djurhuus GW, Joensen JE, Køtlum JE, Hansen SÓ, Sander BB, Mogensen O, Rebolj M. Hammer T, et al. Among authors: rebolj m. Acta Oncol. 2015 Feb;54(2):210-6. doi: 10.3109/0284186X.2014.986287. Epub 2014 Dec 15. Acta Oncol. 2015. PMID: 25495570

10

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years.

Rebolj M, Bonde J, Ejegod D, Preisler S, Rygaard C, Lynge E. Rebolj M, et al. Eur J Cancer. 2015 Jul;51(11):1456-66. doi: 10.1016/j.ejca.2015.04.012. Epub 2015 May 12. Eur J Cancer. 2015. PMID: 25979832 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page